2025 Update in Hematology and Medical Oncology — On Demand
This 13th Annual Board Review and Comprehensive Update in Hematology and Medical Oncology offers an in-depth and current review of the diagnosis, staging,and management of neoplastic diseases,encompassing both solid tumors and hematologic malignancies. Expert-led lectures and discussions cover disease-specific topics across gastrointestinal, gynecologic, thoracic, ead and neck, genitourinary, soft tissue and skin, and central nervous system cancers, as well as hematologic malignancies. This program is designed to support participants in their preparation for the American Board of Internal Medicine (ABIM) certification and recertification examinations in Hematology and Medical Oncology and is now avaible on Medustudy website
Videos+PDFs
topcs
Solid Tumors
COLON CANCER Leonard Saltz, MD
Executive Director for Clinical Value & Sustainability;
Head, Colorectal Oncology Section;
Attending Physician, Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical Center
MELANOMA Michael A. Postow, MD
Chief, Melanoma Service;
Co-Director, Melanoma Disease Management Team
Memorial Sloan Kettering Cancer Center
KIDNEY CANCER Robert J. Motzer, MD
Section Head, Kidney Cancer;
Jack and Dorothy Byrne Chair in Clinical Oncology;
Attending Physician, Genitourinary Oncology Service
Memorial Sloan Kettering Cancer Center
PROSTATE CANCER Susan F. Slovin, MD, PhD
Associate Vice Chair, Academic Affairs,
Department of Medicine;
Attending Physician, Genitourinary Oncology Service
& Cellular Therapy Service
Memorial Sloan Kettering Cancer Center
MESOTHELIOMA Michael D. Offin, MD
Co-Director, Mesothelioma Program;
Assistant Attending Physician, Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
UROTHELIAL CANCER Gopa Iyer, MD
Section Head, Bladder Cancer;
Associate Attending Physician, Genitourinary Oncology Service
& Early Drug Development Service
Memorial Sloan Kettering Cancer Center
TESTIS CANCER Darren R. Feldman, MD
Chair, Quality Assurance;
Section Head, Germ Cell Cancer;
Associate Attending Physician, Genitourinary Oncology Service
Memorial Sloan Kettering Cancer Center
Associate Professor of Medicine, Weill Cornell Medical College
UTERINE, CERVIX, AND
OTHER GYNECOLOGIC
CANCERS
Carol Aghajanian, MDChief, Gynecologic Medical Oncology Service;
Avon Chair in Gynecologic Oncology Research
Memorial Sloan Kettering Cancer Center
OVARIAN CANCER Rachel N. Grisham, MD
Section Head, Ovarian Cancer;
Director, Gynecologic Medical Oncology, MSK Westchester;
Associate Attending Physician,
Gynecologic Medical Oncology Service
Memorial Sloan Kettering Cancer Center
BREAST CANCER
SURGERY
Anita Mamtani, MD, FACS
Surgical Site Director, MSK Bergen;
Assistant Attending Surgeon, Breast Service
Memorial Sloan Kettering Cancer Center
BREAST CANCER
RADIATION THERAPY
Lior Z. Braunstein, MD
Associate Attending Radiation Oncologist,
External Beam Radiotherapy Service
Memorial Sloan Kettering Cancer Center
HEREDITARY CANCER
GENETICS
Zsofia K. Stadler, MD
Clinical Director, Clinical Genetics Service;
Associate Attending Physician, Clinical Genetics Service
& Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center
SMALL CELL LUNG



